GlassScriptPhysician profile
Pranav D Dadhich
NPI 1053845362
$56,304.48
in general payments reported to CMS, 2019-2025
28 companies · $871 in 2025
The $871 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.08 · 2022: $52K · 2023: $2,193 · 2024: $1,336 · 2025: $871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,808 · Travel and Lodging: $1,592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,807.88 |
| Travel and Lodging | $1,591.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $52,309.72 | 2021-2025 | Ams 700, General - Erectile Dysfunction |
| Coloplast Corp | $2,588.41 | 2022-2025 | Titan |
| Teleflex LLC | $177.98 | 2024-2025 | Urolift |
| Janssen Biotech, INC. | $147.41 | 2024-2025 | Erleada, Akeega |
| Abbvie INC. | $122.43 | 2024-2025 | |
| Endo USA, INC. | $108.45 | 2024-2025 | Xiaflex, Aveed |
| Astellas Pharma US INC | $99.20 | 2025 | Xtandi |
| Valencia Technologies Corporation | $89.77 | 2025 | Ecoin Device Kit |
| Sumitomo Pharma America, INC. | $79.04 | 2024-2025 | Orgovyx, Gemtesa |
| Edap Technomed INC | $61.19 | 2025 | |
| Procept Biorobotics Corporation | $54.02 | 2024 | Aquabeam System |
| 180 Medical, INC. | $52.68 | 2024 | |
| Immunitybio, INC. | $51.65 | 2025 | |
| Urogen Pharma, INC. | $50.95 | 2025 | |
| Eisai INC. | $35.51 | 2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $30.91 | 2025 | Adstiladrin |
| Accord Healthcare, INC. | $30.15 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.11 | 2024 | |
| Pfizer INC. | $24.64 | 2025 | |
| Innovation Technologies INC | $24.19 | 2025 | Irrisept |
| Cook Medical LLC | $21.21 | 2024 | Resonance |
| Progenics Pharmaceuticals, INC. | $19.74 | 2024 | |
| Endo Pharmaceuticals INC. | $19.30 | 2024 | Xiaflex |
| Verity Pharmaceuticals INC. | $19.21 | 2025 | Trelstar |
| Axonics, INC. | $18.69 | 2024 | Bulkamid |
| Astrazeneca Pharmaceuticals LP | $18.02 | 2025 | Lynparza |
| Tolmar, INC. | $17.12 | 2024 | |
| Mission Pharmacal Company | $6.78 | 2024 | Uribel Tabs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pranav Dadhich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.